Advertisement
LMAT vs PDEX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMAT is a StrongBuy and PDEX is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LMAT’s FA Score shows that 2 FA rating(s) are green whilePDEX’s FA Score has 0 green FA rating(s).
- LMAT’s FA Score: 2 green, 3 red.
- PDEX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LMAT’s TA Score shows that 3 TA indicator(s) are bullish while PDEX’s TA Score has 4 bullish TA indicator(s).
- LMAT’s TA Score: 3 bullish, 3 bearish.
- PDEX’s TA Score: 4 bullish, 4 bearish.
Price Growth
LMAT (@Medical Specialties) experienced а +0.97% price change this week, while PDEX (@Medical Specialties) price change was +10.71% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +1.35%, and the average quarterly price growth was -0.23%.
Reported Earning Dates
LMAT is expected to report earnings on Jul 24, 2025.
PDEX is expected to report earnings on Aug 28, 2025.
Industries' Descriptions
@Medical Specialties (+1.08% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| LMAT | PDEX | LMAT / PDEX | |
| Capitalization | 1.48B | 61.8M | 2,398% |
| EBITDA | 49M | 5.58M | 878% |
| Gain YTD | -9.949 | -4.000 | 249% |
| P/E Ratio | 49.19 | 20.89 | 235% |
| Revenue | 193M | 48.2M | 400% |
| Total Cash | 105M | 7.09M | 1,481% |
| Total Debt | 19.1M | 13.5M | 141% |
LMAT | PDEX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 25 | 38 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 21 Undervalued | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 19 | 46 | |
SMR RATING 1..100 | 57 | 34 | |
PRICE GROWTH RATING 1..100 | 58 | 42 | |
P/E GROWTH RATING 1..100 | 80 | 95 | |
SEASONALITY SCORE 1..100 | 26 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LMAT's Valuation (21) in the Medical Specialties industry is somewhat better than the same rating for PDEX (66) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew somewhat faster than PDEX’s over the last 12 months.
LMAT's Profit vs Risk Rating (19) in the Medical Specialties industry is in the same range as PDEX (46) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew similarly to PDEX’s over the last 12 months.
PDEX's SMR Rating (34) in the Medical Or Nursing Services industry is in the same range as LMAT (57) in the Medical Specialties industry. This means that PDEX’s stock grew similarly to LMAT’s over the last 12 months.
PDEX's Price Growth Rating (42) in the Medical Or Nursing Services industry is in the same range as LMAT (58) in the Medical Specialties industry. This means that PDEX’s stock grew similarly to LMAT’s over the last 12 months.
LMAT's P/E Growth Rating (80) in the Medical Specialties industry is in the same range as PDEX (95) in the Medical Or Nursing Services industry. This means that LMAT’s stock grew similarly to PDEX’s over the last 12 months.
| LMAT | PDEX | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 84% |
| Stochastic ODDS (%) | 3 days ago 58% | 3 days ago 76% |
| Momentum ODDS (%) | 3 days ago 80% | 3 days ago 80% |
| MACD ODDS (%) | 3 days ago 75% | 3 days ago 87% |
| TrendWeek ODDS (%) | 3 days ago 74% | 3 days ago 77% |
| TrendMonth ODDS (%) | 3 days ago 52% | 3 days ago 77% |
| Advances ODDS (%) | 7 days ago 74% | 6 days ago 82% |
| Declines ODDS (%) | 17 days ago 54% | 10 days ago 71% |
| BollingerBands ODDS (%) | N/A | 3 days ago 73% |
| Aroon ODDS (%) | N/A | 3 days ago 73% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PCBIX | 46.91 | 0.35 | +0.75% |
| Principal MidCap Institutional | |||
| CVTCX | 51.53 | 0.30 | +0.59% |
| Calamos Growth & Income C | |||
| ITFEX | 12.87 | 0.05 | +0.39% |
| Voya International High Div Low Vol S2 | |||
| PEXMX | 33.25 | 0.07 | +0.21% |
| T. Rowe Price Extended Equity Market Idx | |||
| RYOAX | 50.80 | -0.28 | -0.55% |
| Rydex Biotechnology H | |||
LMAT and
Correlation & Price change
A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.
| Ticker / NAME | Correlation To LMAT | 1D Price Change % | ||
|---|---|---|---|---|
| LMAT | 100% | +0.21% | ||
| ITGR - LMAT | 48% Loosely correlated | +0.57% | ||
| SYK - LMAT | 47% Loosely correlated | +0.81% | ||
| UFPT - LMAT | 40% Loosely correlated | -1.00% | ||
| AORT - LMAT | 39% Loosely correlated | +1.86% | ||
| PDEX - LMAT | 39% Loosely correlated | +6.45% | ||
More | ||||
PDEX and
Correlation & Price change
A.I.dvisor indicates that over the last year, PDEX has been loosely correlated with LMAT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PDEX jumps, then LMAT could also see price increases.
| Ticker / NAME | Correlation To PDEX | 1D Price Change % | ||
|---|---|---|---|---|
| PDEX | 100% | +6.45% | ||
| LMAT - PDEX | 39% Loosely correlated | +0.21% | ||
| LDXHF - PDEX | 25% Poorly correlated | N/A | ||
| TCMD - PDEX | 24% Poorly correlated | +0.78% | ||
| PRE - PDEX | 23% Poorly correlated | -5.67% | ||
| BDX - PDEX | 23% Poorly correlated | +0.52% | ||
More | ||||